Tango Therapeutics (TNGX) Competitor Comparison
We are evaluating the key criteria listed to compare Tango Therapeutics (TNGX) against its competitors in the Biotechnology industry.
Market Capitalization
116 / 368Gross Profits
226 / 278Total Revenue
135 / 300EBITDA
212 / 337Free Cashflow
240 / 352Quick Ratio
108 / 357Earnings per Share
152 / 359Dividend yield
0 / 6Total Cash
85 / 358Performance 3 years
213 / 368Performance 5 years
196 / 368Performance 10 years
170 / 368Linearity 3 years
133 / 368Linearity 5 years
128 / 368Linearity 10 years
108 / 367Total Rank
358 / 368Dividend Rank
281 / 368Valuation Rank
236 / 368Piotroski Rank
334 / 368Muliplier Rank
215 / 368Market Capitalization - TNGX ranking 116 / 368
Obligatory risk notice
We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.